Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a line of health care products. Co. has four reportable segments: Established Pharmaceutical Products, which sells a line of branded generic pharmaceutical products internationally; Nutritional Products, which sells adult and pediatric nutritional products; Diagnostic Products, which sells diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites; and Cardiovascular and Neuromodulation Products, which include rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases. We show 36 historical shares outstanding datapoints in our coverage of ABT's shares outstanding history.
Understanding the changing numbers of ABT shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like ABT versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching ABT by allowing them to research ABT shares outstanding history
as well as any other stock in our coverage universe. |
Video: Shares Outstanding Importance
